卫健委:重视罕见病群体 让患者有医可寻

2019-02-14 董童、杨迪 人民网-人民健康网

人民网北京2月13日电 13日,国家卫生健康委员会医政医管局副局长焦雅辉在例行发布会上表示,目前,我国罕见病一方面是缺乏有效的诊断和治疗手段,药品供应和常见病的药品供应不一样;另一方面是缺乏药品,能够真正有效的治疗的药本身就有限,部分药品价格高,患者和家庭负担重。针对罕见病防治管理工作,卫健委近年来主要做了五方面工作。

人民网北京2月13日电 13日,国家卫生健康委员会医政医管局副局长焦雅辉在例行发布会上表示,目前,我国罕见病一方面是缺乏有效的诊断和治疗手段,药品供应和常见病的药品供应不一样;另一方面是缺乏药品,能够真正有效的治疗的药本身就有限,部分药品价格高,患者和家庭负担重。针对罕见病防治管理工作,卫健委近年来主要做了五方面工作。

一是划定范围,确定罕见病种类。2018年5月,卫健委和科技部、工信部、国家药监局和国家中医局五部委联合印发了第一批罕见病目录,共收录了121种罕见病。将来随着罕见病诊断和治疗手段的提高,还会再扩充罕见病的目录。同时,制定了纳入目录的工作程序,对目录进行动态调整。

二是制定罕见病的诊疗规范和指南。由于罕见病病种繁多、单一病种患病人数少,目前很多医院的诊断能力和水平相对欠缺,部分罕见病很难在第一时间诊断出来。对此,成立了国家卫生健康委罕见病诊疗和保障专家委员会,并制定相关规范、指南和路径,开展医务人员的培训。同时,组建了罕见病诊疗网络,由国家级牵头医院、省级牵头医院和协作网成员医院组成,全国有300多家医院纳入罕见病诊疗网络。通过相对集中诊疗和双向转诊,为罕见病患者提供较为高效的诊疗服务,延缓疾病的进展,减轻患者痛苦。

三是做好新生儿的筛查。优生优育工作是减少罕见病发生率的一项重要的措施。要构建全国新生儿疾病筛查的网络,从根本上防止和减少罕见病的发生。,不断健全孕前产前检查和疾病筛查制度,努力降低包括罕见病在内的新生儿出生缺陷的发生率,是有效的减少罕见病的手段。

四是开展补助和救助的项目。比如和民政部、慈善组织和社会组织,组建罕见病联盟,通过各方面的社会力量减轻罕见病患者和家庭的经济精神负担。对此,中国罕见病联盟副理事长、秘书长,北京协和医院副院长张抒扬表示,2018年由北京协和医院联合中国医院协会、中国医药促进会等多家医疗机构、学术团体、制药企业成立的中国罕见病联盟具有积极的意义。联盟的成立既可提升医生能力,规范诊疗,做到早期诊断,还能协同医生团队、研究机构和高校,针对罕见病发病机制等需要解决的问题,进行学术研究。

五是同有关部门比如科技部门,加强罕见病相关科技研发。通过新药专项、公益性行业科研专项,国家重点研发计划、精准医学重点专项等,加大对罕见病的诊断治疗科研方面推进的力度。

最后,焦雅辉指出,未来,国家卫健委将按照预防为主、分类施策、稳步推进的原则,采取措施降低罕见病的发生。同时,还将进一步加大诊疗力度,充分发挥网络的作用。建立罕见病登记系统,通过大数据推进下一步的研发和科技攻关。同时,卫健委会动员各方面力量,进一步关爱和支持罕见病患者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717005, encodeId=b87b1e17005cf, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu Feb 14 23:18:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361119, encodeId=de85361119e6, content=这个真心好!支持!, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/81ff04c53a66053ece2d1fb796d2dac0.jpg, createdBy=cc1c2549075, createdName=maomao2019, createdTime=Wed Feb 20 11:49:30 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258550, encodeId=8bef125855099, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467399, encodeId=200f146e3996e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-02-14 xjy13
  2. [GetPortalCommentsPageByObjectIdResponse(id=1717005, encodeId=b87b1e17005cf, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu Feb 14 23:18:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361119, encodeId=de85361119e6, content=这个真心好!支持!, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/81ff04c53a66053ece2d1fb796d2dac0.jpg, createdBy=cc1c2549075, createdName=maomao2019, createdTime=Wed Feb 20 11:49:30 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258550, encodeId=8bef125855099, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467399, encodeId=200f146e3996e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-02-20 maomao2019

    这个真心好!支持!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1717005, encodeId=b87b1e17005cf, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu Feb 14 23:18:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361119, encodeId=de85361119e6, content=这个真心好!支持!, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/81ff04c53a66053ece2d1fb796d2dac0.jpg, createdBy=cc1c2549075, createdName=maomao2019, createdTime=Wed Feb 20 11:49:30 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258550, encodeId=8bef125855099, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467399, encodeId=200f146e3996e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1717005, encodeId=b87b1e17005cf, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu Feb 14 23:18:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361119, encodeId=de85361119e6, content=这个真心好!支持!, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/81ff04c53a66053ece2d1fb796d2dac0.jpg, createdBy=cc1c2549075, createdName=maomao2019, createdTime=Wed Feb 20 11:49:30 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258550, encodeId=8bef125855099, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467399, encodeId=200f146e3996e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Sat Feb 16 02:18:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-02-16 syscxl